With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus.
The presence, at the time of challenge, of antiviral effector T cells in the vaginal mucosa of female rhesus macaques immunized with live-attenuated simian-human immunodeficiency virus 89.6 (SHIV89.6) is associated with consistent and reproducible protection from pathogenic simian immunodeficiency virus (SIV) vaginal challenge (18). Here, we definitively demonstrate the protective role of the SIV-specific CD8(+) T-cell response in SHIV-immunized monkeys by CD8(+) lymphocyte depletion, an intervention that abrogated SHIV-mediated control of challenge virus replication and largely eliminated the SIV-specific T-cell responses in blood, lymph nodes, and genital mucosa. While in the T-cell-intact SHIV-immunized animals, polyfunctional and degranulating SIV-specific CD8(+) T cells were present in the genital tract and lymphoid tissues from the day of challenge until day 14 postchallenge, strikingly, expansion of SIV-specific CD8(+) T cells in the immunized monkeys was minimal and limited to the vagina. Thus, protection from uncontrolled SIV replication in animals immunized with attenuated SHIV89.6 is primarily mediated by CD8(+) T cells that do not undergo dramatic systemic expansion after SIV challenge. These findings demonstrate that despite, and perhaps because of, minimal systemic expansion of T cells at the time of challenge, a stable population of effector-cytotoxic CD8(+) T cells can provide significant protection from vaginal SIV challenge.
Genescà
Meritxell
M
CNPRC, UC Davis, One Shields Ave., Davis, CA 95616, USA.
Skinner
Pamela J
PJ
Hong
Jung Joo
JJ
Li
Jun
J
Lu
Ding
D
McChesney
Michael B
MB
Miller
Christopher J
CJ
D000818:Animals; D001769:Blood / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D005260:Female; D008198:Lymph Nodes / Q000276:immunology; D008212:Lymphocyte Depletion; D008253:Macaca mulatta; D009092:Mucous Membrane / Q000276:immunology; D018449:SAIDS Vaccines / Q000276:immunology*; D016097:Simian Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D015302:Simian Immunodeficiency Virus / Q000276:immunology*; D014613:Vaccines, Attenuated / Q000276:immunology; D014621:Vagina / Q000276:immunology
D018449:SAIDS Vaccines; D014613:Vaccines, Attenuated
Nat Rev Immunol. 2008 Feb;8(2):107-19
18219309
J Virol. 1994 Sep;68(9):6103-10
8057491
J Virol. 2008 Jun;82(11):5618-30
18367534
J Virol. 2000 Aug;74(16):7485-95
10906202
Clin Exp Immunol. 2002 Apr;128(1):10-20
11982585
J Virol. 2005 Jul;79(13):8131-41
15956558
Cell Mol Life Sci. 2005 Dec;62(23):2853-66
16314932
J Allergy Clin Immunol. 2008 Jul;122(1):3-9; quiz 10-1
18468671
J Exp Med. 2007 Oct 1;204(10):2473-85
17893201
AIDS. 2002 Jul 26;16(11):1489-96
12131186
J Immunol. 2002 Sep 15;169(6):3438-46
12218167
J Exp Med. 2004 Nov 15;200(10):1299-314
15545355
Mucosal Immunol. 2008 May;1(3):219-28
19079181
J Exp Med. 2006 Jun 12;203(6):1533-41
16735692
Lancet Infect Dis. 2008 Feb;8(2):82-3
18060842
AIDS Res Hum Retroviruses. 2001 Oct 10;17(15):1455-66
11679158
J Virol. 2005 Jul;79(14):9217-27
15994816
J Gen Virol. 2004 Sep;85(Pt 9):2591-2602
15302953
Virology. 2005 Mar 15;333(2):226-38
15721357
Clin Infect Dis. 2008 Jun 1;46(11):1769-81
18433307
J Virol. 1999 Jul;73(7):5466-72
10364294
Immunity. 2007 Aug;27(2):281-95
17723218
Eur J Immunol. 2000 Dec;30(12):3598-603
11169402
J Med Primatol. 2006 Aug;35(4-5):202-9
16872283
J Immunol. 2007 Oct 1;179(7):4571-9
17878354
J Virol. 2007 Oct;81(20):10861-8
17670818
J Exp Med. 2007 Jul 9;204(7):1625-36
17606632
J Immunol. 2000 Jul 15;165(2):613-7
10878330
J Virol. 2002 Jul;76(14):7187-202
12072518
J Immunol. 2007 Oct 1;179(7):4732-40
17878372
Science. 1999 Feb 5;283(5403):857-60
9933172
Science. 2008 May 9;320(5877):760-4
18467582
Virology. 2000 Jan 5;266(1):203-10
10612675
J Immunol. 2008 Apr 15;180(8):5439-47
18390726
J Exp Med. 1999 Mar 15;189(6):991-8
10075982
J Virol. 2001 Feb;75(3):1507-15
11152522
Immunol Res. 2008;40(3):235-43
17989940
J Virol. 2003 Mar;77(5):3099-118
12584336
J Immunol. 2008 Jan 1;180(1):350-60
18097036
Science. 2008 May 9;320(5877):753-5
18467578
J Virol. 2005 Dec;79(23):14986-91
16282500
Blood. 2006 Jun 15;107(12):4781-9
16467198
J Exp Med. 2000 Jul 3;192(1):63-75
10880527
J Virol. 2006 May;80(10):5074-7
16641299
J Immunol. 2004 Oct 15;173(8):5064-76
15470050
J Virol. 2005 Nov;79(22):14355-70
16254370
Annu Rev Immunol. 2003;21:515-46
12500980
Microbes Infect. 2003 Jan;5(1):59-67
12593974
N Engl J Med. 2007 Dec 27;357(26):2653-5
18160684
J Virol. 2005 Jul;79(14):9228-35
15994817
J Virol. 2003 Dec;77(24):13348-60
14645590
J Virol. 1997 Mar;71(3):1911-21
9032322
J Immunol Methods. 2002 Oct 1;268(1):29-34
12213340
J Virol. 2008 Jul;82(13):6758-61
18434394
J Virol. 1994 Jul;68(7):4650-5
8207839
J Immunol. 1998 Jun 15;160(12):6062-71
9637523